371 related articles for article (PubMed ID: 31597721)
1. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
3. Fully Attenuated
Sun A; Zhao X; Zhu X; Kong Z; Liao Y; Teng M; Yao Y; Luo J; Nair V; Zhuang G; Zhang G
Microbiol Spectr; 2022 Dec; 10(6):e0287122. PubMed ID: 36350141
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
5. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
[TBL] [Abstract][Full Text] [Related]
10. Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease.
Lee LF; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Vaccine; 2012 Jul; 30(34):5151-8. PubMed ID: 22687760
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
12. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
Schat KA
Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
[TBL] [Abstract][Full Text] [Related]
13. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
14. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
Gimeno IM; Dunn JR; Cortes AL; El-Gohary Ael-G; Silva RF
Avian Dis; 2014 Jun; 58(2):232-43. PubMed ID: 25055627
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
[TBL] [Abstract][Full Text] [Related]
16. Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.
Baigent SJ; Nair VK; Le Galludec H
J Virol Methods; 2016 Jul; 233():23-36. PubMed ID: 26973285
[TBL] [Abstract][Full Text] [Related]
17. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
Davidson I; Natour-Altoury A; Raibstein I; Dahan Y
Avian Pathol; 2017 Dec; 46(6):610-614. PubMed ID: 28532188
[TBL] [Abstract][Full Text] [Related]
18. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
19. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
[TBL] [Abstract][Full Text] [Related]
20. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
